-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-01-12
Values as of: 2025-01-12
The investment seeks to provide investment returns that closely correspond to the price and yield performance of the Nasdaq Composite Index?. The fund normally invests at least 80% of assets in common stocks included in the index. It uses statistical sampling techniques that take into account such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to create a portfolio of securities listed in the Nasdaq Composite Index that have a similar investment profile to the entire index.
Company Website : www.fidelity.com
Currency: USD
Country : USA
Inception Date: 21/10/2013
Primary Benchmark: MSCI USA IMI/Financials GR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.12%
Management Expense Ratio: 0.08 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
CVE | Cenovus Energy Inc | 6.60 % |
EMMA | Emmaus Life Sciences Inc | 5.33 % |
ABL | Abacus Life Inc. | 4.01 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
XLF | Financial Select Sector SPDR®.. | 0.13 % |
+0.34 (+0.72%) |
USD 46.80B |
VFH | Vanguard Financials Index Fund.. | 0.10 % |
+0.72 (+0.62%) |
USD 11.44B |
FXO | First Trust Financials AlphaDE.. | 0.63 % |
+0.31 (+0.59%) |
USD 2.01B |
BIZD | VanEck BDC Income ETF | 0.41 % |
+0.07 (+0.43%) |
USD 1.35B |
VPC | Virtus Private Credit ETF | 0.00 % |
+0.01 (+0.05%) |
USD 0.05B |
BDCZ | UBS AG London Branch ELKS 4 | 0.00 % |
-0.20 (-1.05%) |
USD 0.02B |
IYF | iShares U.S. Financials ETF | 0.42 % |
+0.83 (+0.77%) |
N/A |
IAI | iShares U.S. Broker-Dealers & .. | 0.42 % |
-0.08 (-0.06%) |
N/A |
IYG | iShares U.S. Financial Service.. | 0.42 % |
+0.49 (+0.64%) |
N/A |
IAK | iShares U.S. Insurance ETF | 0.43 % |
+1.02 (+0.84%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
JMBS | Janus Henderson Mortgage-.. | 0.52 % | 0.35 % |
-0.13 (0%) |
USD 4.63B |
JAGG | 0.00 % | 0.07 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Financial) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -2.11% | 47% | F | 28% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -2.11% | 47% | F | 28% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 26.54% | 76% | C+ | 85% | B | ||
Dividend Return | 1.46% | 24% | F | 23% | F | ||
Total Return | 28.00% | 76% | C+ | 84% | B | ||
Trailing 5 Years | |||||||
Capital Gain | 51.21% | 59% | D- | 76% | C+ | ||
Dividend Return | 10.86% | 29% | F | 34% | F | ||
Total Return | 62.07% | 53% | F | 75% | C | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 17.10% | 65% | D | 78% | C+ | ||
Dividend Return | 19.06% | 65% | D | 78% | C+ | ||
Total Return | 1.96% | 53% | F | 47% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 26.62% | 59% | D- | 41% | F | ||
Risk Adjusted Return | 71.61% | 59% | D- | 82% | B | ||
Market Capitalization | 0.38B | 71% | C- | 67% | D+ |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.